European Drug Agency Supports Novo Nordisk's Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure
Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart failure symptoms, physical limitations, and exercise function in patients with obesity-related HFpEF.
For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...
CINCINNATI ( WXIX /Gray News) - A 7-year-old is in a hospital in Ohio fighting for her life after experiencing her second heart failure. Nyla Pritchett has been at Cincinnati Children’s Hospital since ...
Edgewise Therapeutics's hypertrophic cardiomyopathy (HCM) asset has started off with a bang after early safety data sent the ...
However, damaged heart vessels can result in abnormal blood flow, potentially causing tissue injury leading to heart ...
In addition to improving heart failure symptoms, finerenone reduced the onset of new type 2 diabetes in patients with mildly ...
Hope Unlimited Ministries will have its annual fundraising event featuring Point of Grace on Thursday, Oct. 17. This event ...
Early identification of kidney dysfunction in patients with advanced heart failure is crucial for timely interventions. In ...
The kidney health benefits of SGLT2 inhibitors extend to patient subgroups with chronic kidney disease (CKD) in combo with other conditions.
Heart failure arises when the heart cannot pump blood efficiently, leading to symptoms such as shortness of breath and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback